Oral intake of royal jelly improves anti-cancer effects and suppresses adverse events of molecular targeted therapy by regulating TNF-α and TGF-β in renal cell carcinoma: A preliminary study based on a randomized double-blind clinical trial

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Miyata, Yasuyoshi, Araki, Kyohei, Ohba, Kojiro, Mastuo, Tomhiro, Nakamura, Yuichiro, Yuno, Tsutomu, Mukai, Yuta, Otsubo, Asato, Mitsunari, Kensuke, Mochizuki, Yasushi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549394/
https://www.ncbi.nlm.nih.gov/pubmed/33062268
http://dx.doi.org/10.3892/mco.2020.2148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549394/
https://www.ncbi.nlm.nih.gov/pubmed/33062268
http://dx.doi.org/10.3892/mco.2020.2148

Ejemplares similares